scout

Lisa Carey, MD, FASCO, UNC Lineberger Comprehensive Cancer Center

Articles by Lisa Carey, MD, FASCO, UNC Lineberger Comprehensive Cancer Center

Refining Treatment Approaches for HER2+ Breast Cancer

ByJoyce A. O'Shaughnessy, MD, Baylor Charles A. Sammons Cancer Center,Lisa Carey, MD, FASCO, UNC Lineberger Comprehensive Cancer Center,Vijayakrishna Gadi, MD, University of Illinois College of Medicine,William Gradishar, MD, Northwestern Medicine,Claudine Isaacs, MD, Lombardi Comprehensive Cancer Center

A discussion on systemic treatment for HER2+ breast cancer and the impact of recent clinical trial data on decision making, including data discussed at the ESMO and SABCS 2020 Annual Meetings.